Home
>
Section
>
Chapter
Alföldi, M.; Ferianec, V.ír.
Archives of Gynecology and Obstetrics 310(1): 615-626
2024
ISSN/ISBN: 1432-0711 PMID: 38642127 Accession:091357549Full-Text Article emailed within 1 workday
Payments are secure & encrypted
Summary
Spontaneous previable rupture of membranes complicates approximately 0.4-0.7% of pregnancies and is associated with severe maternal and neonatal morbidity and mortality. Intra-amniotic inflammation is present in up to 94.4% of cases, most often caused by a bacterial infection. In comparison, the effectiveness of antibiotic therapy in its eradication reaches less than 17%. Inflammatory activity in the amniotic cavity disrupts the physiological development of the fetus with an increase in maternal, fetal, and neonatal inflammatory morbidity through the development of fetal inflammatory response syndrome, maternal chorioamnionitis, and neonatal sepsis. Amniopatch is an invasive therapeutic technique based on intra-amniotic administration of maternal hemoderivates in the form of thromboconcentrate and plasma cryoprecipitate to provide the temporary closure of the fetal membranes defect and secondary restitution of normohydramnios with correction of pressure-volume ratios. The supposed basis of this physical-mechanical action is the aggregation of coagulant components of amniopatch in the area of the defect with the formation of a valve cap. The background for the formulation of the hypothesis on the potential anti-infectious and anti-inflammatory action of non-coagulant components of amniopatch involved: i) clinical-academic and publishing outputs of the authors based on their many years' experience with amniopatch application in the treatment of spontaneous previable rupture of membranes (2008-2019), ii) the documented absence of clinically manifested chorioamnionitis in patients treated this way with a simultaneously reduced incidence of neonatal respiratory distress syndrome compared to expectant management (tocolysis, corticotherapy, antibiotic therapy). The non-coagulant components of plasma cryoprecipitate include mainly naturally occurring isohemagglutinins, albumin, and soluble plasma fibrinogen. Although these components of the amniopatch have not been attributed a significant therapeutic role, the authors assume that due to their opsonizing and aggregative properties, they can significantly participate in optimizing the intrauterine environment through the reduction in bacterial and cytokine charge in the amniotic fluid. The authors think these facts constitute a vital stimulus to future research-academic activity and, at the same time, an idea for reconsidering the therapeutic role of amniopatch as a tool for improving perinatal results of spontaneous previable ruptures of membranes.References
Ferianec, V.ír.; Križko, M.án.; Gábor, M.; Papcun, P.; Alföldi, M.; Feriancová, M. 2022: Amniopatch as an active treatment of spontaneous previable rupture of membranes Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 35(25): 9900-9906
Kwak, H.-M.; Choi, H.-J.; Cha, H.-H.; Yu, H.-J.; Lee, J.-H.; Choi, S.-J.; Oh, S.-Y.; Roh, C.-R.; Kim, J.-H. 2013: Amniopatch treatment for spontaneous previable, preterm premature rupture of membranes associated or not with incompetent cervix Fetal Diagnosis and Therapy 33(1): 47-54
Alfoldi, M.; Papcun, P.; Krizko, M.; Gabor, M.; Feriancova, M.; Gazdarica, J.; Ferianec, V. 2022: Is amniopatch an effective treatment for spontaneous previable premature rupture of membranes? Analysis of perinatal outcome Bratislavske Lekarske Listy 123(5): 326-333
Ferianec, V.ír.; Krizko, M.; Papcun, P.; Svitekova, K.; Cizmar, B.; Holly, I.; Holoman, K. 2011: Amniopatch - possibility of successful treatment of spontaneous previable rupture of membranes in the second trimester of pregnancy by transabdominal intraamiotic application of platelets and cryoprecipitate Neuro Endocrinology Letters 32(4): 449-452
Quintero, R.; Chmait, R.; Rossi, C.; Allen, M.; Bornick, P.W. 2004: OC033: Treatment of previable iatrogenic rupture of membranes with the amniopatch: rationale for a randomized clinical trial Ultrasound in Obstetrics and Gynecology 24(3): 225-225
Quintero, R.A.; Morales, W.J.; Allen, M.; Bornick, P.W.; Arroyo, J.; LeParc, G. 1999: Treatment of iatrogenic previable premature rupture of membranes with intra-amniotic injection of platelets and cryoprecipitate (amniopatch): Preliminary experience American Journal of Obstetrics and Gynecology 181(3): 744-749
Richter, J.; Henry, A.; Ryan, G.; DeKoninck, P.; Lewi, L.; Deprest, J. 2013: Amniopatch procedure after previable iatrogenic rupture of the membranes: a two-center review Prenatal Diagnosis 33(4): 391-396
Maged, A.M.; Kamel, H.H.; Sanad, A.S.; Mahram, A.E.; AbdAllah, A.A.; Elkhateeb, R.; Bhaa, H.A.; Hussein, E.A.; Essam, A.; Ibrahim, S. 2021: The value of amniopatch in pregnancies associated with spontaneous preterm premature rupture of fetal membranes: a randomized controlled trial Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 34(2): 267-273
Deprest, J.; Van Mieghem, T.; Emonds, M.P.; Richter, J.; De Koninck, P.; Zia, S.; Van Keirsbilck, J.; Sandaite, I.; Olde Damink, L.; Lewi, L. 2011: Traitement de la rupture iatrogène des membranes fœtales par « patch » amniotique : Rupture des Membranes Foetales - Amniopatch to treat iatrogenic rupture of the fetal membranes le Groupe de Recherche et Detude du Placenta 39(6): 378-382
Mandelbrot, L.; Bourguignat, L.; Mellouhi, I.S.; Gavard, L.; Morin, F.; Bierling, P. 2009: Treatment by autologous amniopatch of premature rupture of membranes following mid-trimester amniocentesis Ultrasound in Obstetrics and Gynecology: the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 33(2): 245-246
Quintero, R.A.; Morales, W.J.; Kalter, C.S.; Angel, J.L.; Sudz, C.; Acuna, E.M.; Romero, R.; Evans, M.I. 1998: Treatment of preterm premature rupture of membranes with an amniopatch Preliminary experience American Journal of Obstetrics and Gynecology 178(1 Part 2): S197
Cobo, T.; Borrell, A.; Fortuny, A.; Hernández, S.; Pérez, M.; Palacio, M.; Pereira, A.; Coll, O. 2007: Treatment with amniopatch of premature rupture of membranes after first-trimester chorionic villus sampling Prenatal Diagnosis 27(11): 1024-1027
Sung, J.-H.; Kuk, J.-Y.; Cha, H.-H.; Choi, S.-J.; Oh, S.-Y.; Roh, C.-R.; Kim, J.-H. 2017: Amniopatch treatment for preterm premature rupture of membranes before 23 weeks' gestation and factors associated with its success Taiwanese Journal of Obstetrics and Gynecology 56(5): 599-605
Fautrel, B.; Cherin, P. 2000: Intérêt des molécules anti-TNF-α dans les maladies inflammatoires et infectieuses - Interest of anti-TNF-α treatment in inflammatory and infectious diseases la Revue de Medecine Interne (Paris) 21(10): 872-888
Erez, O.; Romero, R.; Tarca, A.L.; Chaiworapongsa, T.; Kim, Y.M.; Than, N.G.; Vaisbuch, E.; Draghici, S.; Tromp, G. 2009: Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 22(12): 1103-1115
Raffi, A.; Hatt, J.J.; Lonchamp, D.; Hardy, J. 1965: The problem of preventive anti-infectious therapeutics in the newborn after premature rupture of the membranes Pediatrie 20(4): 480-483
Sipurzynski-Budrass, S.; Macher, S.; Haeusler, M.; Lanzer, G. 2006: Successful treatment of premature rupture of membranes after genetic amniocentesis by intra-amniotic injection of platelets and cryoprecipitate (amniopatch): a case report Vox Sanguinis 91(1): 88-90
Sarkar, R.; Ghosh, A.; Barui, A.; Datta, P. 2018: Repositing honey incorporated electrospun nanofiber membranes to provide anti-oxidant, anti-bacterial and anti-inflammatory microenvironment for wound regeneration Journal of Materials Science. Materials in Medicine 29(3): 31
Altay, B.; Girgin, C.; Cikili, N. 1999: Comparing the anti-inflammatory effects of corticotherapy and non-steroid anti-inflammatory drugs in infertile patients with infectious aetiology International Urology and Nephrology 31(1): 101-106
Guerich H G. 1970: Fatal hemorrhaging in the abdominal cavity during non traumatic rupture of the spleen bilateral spontaneous rupture during anti coagulant treatment Verhandlungen der Deutschen Gesellschaft fuer Pathologie 54: 680-681
